| Views | |
|---|---|
| Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials | 125 |
| November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | |
|---|---|---|---|---|---|---|---|
| Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials | 7 | 0 | 9 | 11 | 8 | 3 | 5 |
| Views | |
|---|---|
| Alkhawaldeh_Evaluation_23.pdf | 53 |
| Views | |
|---|---|
| Canada | 33 |
| United States | 27 |
| Germany | 4 |
| India | 4 |
| Vietnam | 3 |
| China | 2 |
| Japan | 2 |
| Latvia | 2 |
| Australia | 1 |
| Netherlands | 1 |
| Views | |
|---|---|
| Ottawa | 29 |
| Durham | 4 |
| Mumbai | 4 |
| Mountain View | 3 |
| Sacramento | 2 |
| San Francisco | 2 |
| Washington | 2 |
| Amsterdam | 1 |
| Baltimore | 1 |
| Bucharest | 1 |